CSF Parameters, Diagnostics, and MRI Findings Prior to and at the Time of Subarachnoid Neurocysticercosis Diagnosis.
. | CSF Parameters . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|
Time Point . | WBC, Cells/mm3 . | Neutrophil, % . | Lymphocyte, % . | Eosinophil, % . | Protein, mg/dL . | Glucose, mg/dL . | T solium IgG ELISA . | QuantiFERON Gold . | Reported Brain MRI Findings . |
Patient 1 | Negative | ||||||||
1: 5 y prior to diagnosis | 35 | … | … | … | 36 | 94 | … | Cystic CSF isointense process expanding the quadrigeminal, ambient, suprasellar, and central sylvian cisterns with displacement of the upper brainstem | |
At diagnosis | 235 | 8 | 71 | 11 | 129 | 62 | Positive | Large multilobulated extra-axial cystic mass involving multiple cisterns; enlarging and consistent with epidermoid cyst | |
Patient 2 | Negative | ||||||||
2 y prior to diagnosis | 68 | … | 79 | 8 | … | … | Positive | Basilar meningitis and communicating hydrocephalus | |
At diagnosis | 27 | 0 | 80 | 10 | 123 | 43 | Negative | Stable basilar leptomeningeal enhancement | |
Patient 3 | Positive | ||||||||
4 mo prior to diagnosis | 6 | 8 | 6 | 10 | 21 | 56 | … | Chronic hydrocephalus and papilledema | |
At diagnosis | 56 | … | 58 | 22 | 42 | 52 | Positive | Leptomeningeal enhancement at basal cisterns; enlargement and possible septations of basal cisterns |
. | CSF Parameters . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|
Time Point . | WBC, Cells/mm3 . | Neutrophil, % . | Lymphocyte, % . | Eosinophil, % . | Protein, mg/dL . | Glucose, mg/dL . | T solium IgG ELISA . | QuantiFERON Gold . | Reported Brain MRI Findings . |
Patient 1 | Negative | ||||||||
1: 5 y prior to diagnosis | 35 | … | … | … | 36 | 94 | … | Cystic CSF isointense process expanding the quadrigeminal, ambient, suprasellar, and central sylvian cisterns with displacement of the upper brainstem | |
At diagnosis | 235 | 8 | 71 | 11 | 129 | 62 | Positive | Large multilobulated extra-axial cystic mass involving multiple cisterns; enlarging and consistent with epidermoid cyst | |
Patient 2 | Negative | ||||||||
2 y prior to diagnosis | 68 | … | 79 | 8 | … | … | Positive | Basilar meningitis and communicating hydrocephalus | |
At diagnosis | 27 | 0 | 80 | 10 | 123 | 43 | Negative | Stable basilar leptomeningeal enhancement | |
Patient 3 | Positive | ||||||||
4 mo prior to diagnosis | 6 | 8 | 6 | 10 | 21 | 56 | … | Chronic hydrocephalus and papilledema | |
At diagnosis | 56 | … | 58 | 22 | 42 | 52 | Positive | Leptomeningeal enhancement at basal cisterns; enlargement and possible septations of basal cisterns |
Ellipses (…) indicate data not available/not reported.
Abbreviations: CSF, cerebral spinal fluid; ELISA, enzyme-linked immunosorbent assay; MRI, magnetic resonance imaging; T solium, Taenia solium; WBC, white blood cell.
CSF Parameters, Diagnostics, and MRI Findings Prior to and at the Time of Subarachnoid Neurocysticercosis Diagnosis.
. | CSF Parameters . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|
Time Point . | WBC, Cells/mm3 . | Neutrophil, % . | Lymphocyte, % . | Eosinophil, % . | Protein, mg/dL . | Glucose, mg/dL . | T solium IgG ELISA . | QuantiFERON Gold . | Reported Brain MRI Findings . |
Patient 1 | Negative | ||||||||
1: 5 y prior to diagnosis | 35 | … | … | … | 36 | 94 | … | Cystic CSF isointense process expanding the quadrigeminal, ambient, suprasellar, and central sylvian cisterns with displacement of the upper brainstem | |
At diagnosis | 235 | 8 | 71 | 11 | 129 | 62 | Positive | Large multilobulated extra-axial cystic mass involving multiple cisterns; enlarging and consistent with epidermoid cyst | |
Patient 2 | Negative | ||||||||
2 y prior to diagnosis | 68 | … | 79 | 8 | … | … | Positive | Basilar meningitis and communicating hydrocephalus | |
At diagnosis | 27 | 0 | 80 | 10 | 123 | 43 | Negative | Stable basilar leptomeningeal enhancement | |
Patient 3 | Positive | ||||||||
4 mo prior to diagnosis | 6 | 8 | 6 | 10 | 21 | 56 | … | Chronic hydrocephalus and papilledema | |
At diagnosis | 56 | … | 58 | 22 | 42 | 52 | Positive | Leptomeningeal enhancement at basal cisterns; enlargement and possible septations of basal cisterns |
. | CSF Parameters . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|
Time Point . | WBC, Cells/mm3 . | Neutrophil, % . | Lymphocyte, % . | Eosinophil, % . | Protein, mg/dL . | Glucose, mg/dL . | T solium IgG ELISA . | QuantiFERON Gold . | Reported Brain MRI Findings . |
Patient 1 | Negative | ||||||||
1: 5 y prior to diagnosis | 35 | … | … | … | 36 | 94 | … | Cystic CSF isointense process expanding the quadrigeminal, ambient, suprasellar, and central sylvian cisterns with displacement of the upper brainstem | |
At diagnosis | 235 | 8 | 71 | 11 | 129 | 62 | Positive | Large multilobulated extra-axial cystic mass involving multiple cisterns; enlarging and consistent with epidermoid cyst | |
Patient 2 | Negative | ||||||||
2 y prior to diagnosis | 68 | … | 79 | 8 | … | … | Positive | Basilar meningitis and communicating hydrocephalus | |
At diagnosis | 27 | 0 | 80 | 10 | 123 | 43 | Negative | Stable basilar leptomeningeal enhancement | |
Patient 3 | Positive | ||||||||
4 mo prior to diagnosis | 6 | 8 | 6 | 10 | 21 | 56 | … | Chronic hydrocephalus and papilledema | |
At diagnosis | 56 | … | 58 | 22 | 42 | 52 | Positive | Leptomeningeal enhancement at basal cisterns; enlargement and possible septations of basal cisterns |
Ellipses (…) indicate data not available/not reported.
Abbreviations: CSF, cerebral spinal fluid; ELISA, enzyme-linked immunosorbent assay; MRI, magnetic resonance imaging; T solium, Taenia solium; WBC, white blood cell.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.